109 related articles for article (PubMed ID: 10787261)
1. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy.
Bell R
BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261
[No Abstract] [Full Text] [Related]
2. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
3. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy.
Ferrini R
Am J Prev Med; 1997; 13(6):444-6. PubMed ID: 9415790
[No Abstract] [Full Text] [Related]
4. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
[TBL] [Abstract][Full Text] [Related]
5. Average-risk screening: is public policy compatible with individual needs?
Levin B; Hawley ST
Surg Oncol Clin N Am; 2000 Oct; 9(4):665-77; discussion 679-81. PubMed ID: 11008231
[TBL] [Abstract][Full Text] [Related]
6. [Screening for ovarian cancer].
Bjørge T; Dørum A; Tropé CG
Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
[TBL] [Abstract][Full Text] [Related]
7. Screening for ovarian cancer: not worthwhile for most patients.
Wong JG; Feussner JR
N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
[No Abstract] [Full Text] [Related]
8. [Problem of uterine and ovarian cancer mass screening].
Ohmura M; Oda M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
[TBL] [Abstract][Full Text] [Related]
9. [Present status and problems of mass screening--from the viewpoint of public health].
Miyake K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
[No Abstract] [Full Text] [Related]
10. Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
Knudsen AB; McMahon PM; Gazelle GS
J Clin Oncol; 2007 Jan; 25(2):203-8. PubMed ID: 17210941
[TBL] [Abstract][Full Text] [Related]
11. [Screening of colorectal cancer in Finland and analysis of its cost-effectiveness].
Malila N; Anttila A; Elovainio L; Hakulinen T; Järvinen H; Paimela H; Pikkarainen P; Rautalahti M; Hakama M
Duodecim; 2003; 119(12):1115-23. PubMed ID: 12868357
[No Abstract] [Full Text] [Related]
12. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
13. Screening for lung cancer: can it be cost-effective?
Miettinen OS
CMAJ; 2000 May; 162(10):1431-6. PubMed ID: 10834047
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
Berchi C; Bouvier V; Réaud JM; Launoy G
Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
[TBL] [Abstract][Full Text] [Related]
15. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
Legood R; Wolstenholme J; Gray A
Health Policy; 2009 Feb; 89(2):193-200. PubMed ID: 18619702
[TBL] [Abstract][Full Text] [Related]
16. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer screening.
Macri CI; DiSaia PJ
West J Med; 1992 Jun; 156(6):652-3. PubMed ID: 1615664
[No Abstract] [Full Text] [Related]
18. [Econometric decisions in public health].
Negrete J
Salud Publica Mex; 1984; 26(4):415-20. PubMed ID: 6435264
[No Abstract] [Full Text] [Related]
19. Screening for ovarian cancer: recommendations and rationale. American College of Physicians.
Ann Intern Med; 1994 Jul; 121(2):141-2. PubMed ID: 8017728
[No Abstract] [Full Text] [Related]
20. Ovarian cancer screening and psychosocial issues: relevance to clinical practice.
Basen-Engquist K
Gynecol Oncol; 1997 May; 65(2):195-6. PubMed ID: 9159324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
